Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library
